AA
Ashish Agarwal
About Ashish Agarwal
Data last updated:
Ashish Agarwal is a Director at Enzyme Office Spaces Private Limited (since 2023) and Director at Uv&Me Offices Private Limited (since 2023). The companies operate in Financial Services and Real Estate. The 2 current companies with reported revenue have a combined latest revenue of ₹46.98 Cr; the largest is Enzyme Office Spaces Private Limited at ₹46.98 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Enzyme Office Spaces Private Limited U70200KA2023PTC170431 | Director | 16 Jan 2023 | 2023 | ₹46.98 Cr (FY 2024) | Active |
| Uv&Me Offices Private Limited U68100KA2023PTC175636 | Director | 05 Jul 2023 | 2023 | ₹2,550 (FY 2025) | Active |
Board colleagues of Ashish Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Basu Agarwal | 03627953 | Enzyme Office Spaces Private Limited | Director |
| Hansa Ruiya | 10738028 | Enzyme Office Spaces Private Limited | Director |
| Kumar Amlendu | 07119545 | Uv&Me Offices Private Limited | Director |
| Piyush Kumar | 07075578 | Uv&Me Offices Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Agarwal
Ashish Agarwal currently holds 2 directorships: Enzyme Office Spaces Private Limited (Director, since 16 Jan 2023, revenue ₹46.98 Cr (FY 2024)); Uv&Me Offices Private Limited (Director, since 05 Jul 2023, revenue ₹2,550 (FY 2025)).
Ashish Agarwal was first appointed on 16 Jan 2023 as Director at Enzyme Office Spaces Private Limited.
The 2 current companies of Ashish Agarwal that report revenue have a combined latest revenue of ₹46.98 Cr: Enzyme Office Spaces Private Limited ₹46.98 Cr (FY 2024); Uv&Me Offices Private Limited ₹2,550 (FY 2025).
The current boards of Ashish Agarwal's companies include Basu Agarwal (Enzyme Office Spaces Private Limited), Hansa Ruiya (Enzyme Office Spaces Private Limited), Kumar Amlendu (Uv&Me Offices Private Limited), Piyush Kumar (Uv&Me Offices Private Limited).